X0508 4 2024-11-19 0 0000907654 Oruka Therapeutics, Inc. ORKA 0001802528 Fairmount Funds Management LLC 200 BARR HARBOR DRIVE SUITE 400 WEST CONSHOHOCKEN PA 19428 1 0 1 0 0001769651 Fairmount Healthcare Fund II L.P. 200 BARR HARBOR DRIVE SUITE 400 WEST CONSHOHOCKEN PA 19428 1 0 1 0 0001830177 Kiselak Tomas 2001 MARKET STREET SUITE 2500 PHILADELPHIA PA 19103 1 0 1 0 0001663607 Harwin Peter Evan 2001 MARKET STREET SUITE 2500 PHILADELPHIA PA 19103 1 0 1 0 0 Common Stock 2024-11-19 4 M 0 160000 A 798614 I By Fairmount Healthcare Fund II L.P. Common Stock 2573308 I By Fairmount Healthcare Co-Invest III L.P. Series A Non-Voting Convertible Preferred Stock 2024-11-19 4 M 0 160 0.00 D Common Stock 160000 0 I By Fairmount Healthcare Fund II L.P. On November 14, 2024, the Issuer's stockholders approved the issuance of Common Stock upon conversion of the Issuer's Series A Non-Voting Convertible Preferred Stock, par value $0.001 per share ("Series A Convertible Preferred Stock") (the "Requisite Stockholder Approval"). Accordingly, pursuant to the terms of the Certificate of Designations of Preferences, Rights and Limitations of Series A Non-Voting Convertible Preferred Stock, 160 shares of Series A Convertible Preferred Stock held by Fairmount Healthcare Fund II LP ("Fund II") were converted into 160,000 shares of Common Stock, effective at 5:00 pm, Eastern Time on November 19, 2024. Fairmount Funds Management LLC ("Fairmount") is the investment manager for Fund II and Fairmount Healthcare Co-Invest III L.P. The general partner of Fairmount is Fairmount Funds Management GP LLC ("Fairmount GP"), of which Peter Harwin and Tomas Kiselak are the managing members. Fairmount, Fairmount GP, Mr. Harwin, and Mr. Kiselak disclaim beneficial ownership of any of the reported securities, except to the extent of their pecuniary interest therein. Following receipt of the Requisite Stockholder Approval, each share of Series A Convertible Preferred Stock automatically converted into 1,000 shares of Common Stock. The Series A Convertible Preferred Stock has no expiration date. Fairmount may be deemed a director by deputization of the Issuer by virtue of the fact that Peter Harwin serves on the board of directors of the Issuer and is also a Managing Member of Fairmount. /s/ Tomas Kiselak, Managing Member of Fairmount Funds Management LLC 2024-11-21 /s/ Tomas Kiselak, Managing Member of Fairmount Healthcare Fund II L.P. 2024-11-21 /s/ Tomas Kiselak 2024-11-21 /s/ Peter Harwin 2024-11-21